The molecular mechanism of P2Y receptor activation by inorganic polyphosphates.

Khondamir R Rustamov, Albert R Makhmudov, Fozila R Ikromova, Ekaterina A Vetrova, Andrey Y Vinokurov, Jamoliddin I Razzokov, Andrey Y Abramov, Artyom Y Baev

Journal: Archives of biochemistry and biophysics 2025;772():110555

PMID: 40684933

Abstract

P2Y receptors (P2YRs) are metabotropic purinoreceptors that can be activated primarily by ADP and, to a lesser extent, by ATP. Recently it was demonstrated that P2YR can be activated by inorganic polyphosphates (polyPs) - molecules, composed solely of orthophosphate residues and lacking a purine part. Although numerous studies have demonstrated that extracellular polyP can transmit signals to neighboring cells via activation of P2YR, the precise molecular mechanisms underlying the activation of P2YR by polyP are still unclear. Here, using all-atom molecular dynamics simulations, we demonstrate that polyP binding to the inactive P2YR induces conformational changes of the receptor, causing its transition into the active state. Binding of polyP-14 to P2YR disrupts the interaction between Asp204 and Arg310 residues, increases the solvent accessible surface area (SASA) of receptor's binding pocket and induces bulk water influx into the receptor inner region. These processes induce conformational changes in the intracellular TM helices, leading to receptor activation similar to that observed in the presence of ADP. In agreement to in silico experiments, application of the same concentrations of polyP and ADP induced calcium signal in skin fibroblasts with similar shape and amplitude. Thus, our findings establish that polyP molecules can bind to and activate P2Y purinoreceptor by molecular mechanism similar to those of its natural ligand ADP. We also propose the hypothesis that interaction of pyrophosphate part of ADP or polyphosphate with certain amino acids is a key event in P2YR activation.

Copyright © 2025 Elsevier Inc. All rights reserved.

Address: Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent, Uzbekistan.; Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent, Uzbekistan; Department of Chemistry, KU Leuven, Celestijnenlaan 200f, Box 2404, 3001, Leuven, Belgium.; Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent, Uzbekistan; Department of Biophysics, Faculty of Biology, National University of Uzbekistan, Tashkent, Uzbekistan.; Cell Physiology and Pathology Laboratory, Orel State University, Orel, 302026, Russia.; Institute of Fundamental and Applied Research, National Research University TIIAME, Kori Niyoziy 39, 100000, Tashkent, Uzbekistan.; Cell Physiology and Pathology Laboratory, Orel State University, Orel, 302026, Russia; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent, Uzbekistan; Cell Physiology and Pathology Laboratory, Orel State University, Orel, 302026, Russia; Department of Biophysics, Faculty of Biology, National University of Uzbekistan, Tashkent, Uzbekistan. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.